हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
GSK
GSK News
Aviation
09 Sep 2022
Pharma giant GSK employee shouts racial slurs on flight, fired: WATCH video
The video has gone viral on the Internet The man mentions we have intoxicated GSK Pharma has fired the man for his actions
GlaxoSmithKline
16 Jan 2022
GSK rejects $68 billion Unilever bid for consumer healthcare unit
GlaxoSmithKline and Unilever confirmed that an acquisition offer was made. There can be no certainty that any agreement will be reached, Unilever said.
COVID-19
17 Aug 2021
GSK-CureVac's 2nd Covid vaccine shows better immune response
The companies aim to roll out CV2CoV's Phase 1 clinical trial in Q4 2021 CureVac's first mRNA-based Covid vaccine CVnCoV, showed efficacy of just 47 percent
COVID-19
08 Jul 2021
DCGI gives nod for Sanofi-GSK's phase 3 trial of COVID vaccine in India
DCGI has given nod for Sanofi-GSK's phase 3 trial of COVID vaccine in India The French pharma company Sanofi and its British peer GSK aim to produce up to one billion doses in 2021
COVID-19
18 May 2021
Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial
Phase-II trial showed 95 per cent to 100 percent seroconversion following a second injection The pharma companies, now, aim to start a global pivotal Phase 3 study in the coming weeks
Paracetamol
28 May 2020
Govt lifts restriction on export of Paracetamol, moves it to free category
The government on Thursday lifted the restrictions imposed on the export of Paracetamol – a medicine which is used in treatment of COVID-19 infection and treating fever.
GSK
07 May 2020
GSK selling $3.45 billion stake in Hindustan Unilever
GSK struck a deal to fold its Indian business - whose main product is Horlicks - into Unilever`s Indian unit Hindustan Unilever in exchange for shares in the combined group.
GSK
03 Jun 2019
GSK Consumers Healthcare gets shareholders' approval for merger with HUL
The company has received 99.99 per cent votes in favour of the scheme of amalgamation among the company and Hindustan Unilever Ltd (HUL) in the National Company Law Tribunal-convened meeting of the equity sharehoders on June 1, 2019.
GlaxoSmithKline
12 Sep 2016
GSK sells anaesthetics to Aspen for up to $370 million
GlaxoSmithKline is to sell its portfolio of anaesthetic drugs to South Africa`s Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.
GlaxoSmithKline
01 Aug 2016
GlaxoSmithKline, Alphabet create $715 million bioelectronics firm
GlaxoSmithKline and Alphabet`s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics.
GlaxoSmithKline
27 May 2016
GSK gets EU approval for first gene therapy for children
The world`s first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering technology to fix faulty genes.
GlaxoSmithKline
17 Mar 2016
GlaxoSmithKline CEO Witty to bow out in March 2017
Witty, a 31-year company veteran, has been under fire from some investors in the past three years as sales and profits have flagged. His reputation was further tarnished by a damaging bribery scandal in China.
Anti-depressants
20 Sep 2015
Popular antidepressant neither safe nor effective for teens
Depressed teens shouldn't take the widely used antidepressant paroxetine as it is neither safe nor effective, as per a reanalysis of an influential study originally published in 2001.
GlaxoSmithKline Pharmaceuticals
02 Aug 2015
GSK Pharma's Bengaluru facility to be operational by 2017
GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017.
GlaxoSmithKline
06 May 2015
GlaxoSmithKline targets growth across units, scraps ViiV listing
GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term growth.
GSK
06 May 2015
New-look GSK bets on consumer health spending
GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.
Sun Pharma
03 Mar 2015
Sun Pharma to buy GSK's opiates business in Australia
The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment.
European Union
28 Jan 2015
EU puts conditions on deals involving Novartis, GSK
The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.
Novartis India
13 Jan 2015
Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr
Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.
GSK
04 Dec 2014
GSK confirms hundreds of US job cuts as market gets tougher
Many of the jobs lost will be from GSK`s Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London.
169130
1
2
Loading...
Trending news
DNA Video
DNA: Trump’s Victory: What Changes Are Coming?
DNA Video
DNA: Yogi’s Bulldozer Politics in Maharashtra
DNA Video
DNA: Article 370 - CM Abdullah’s Gamble Falls Short?
DNA Video
DNA: Supreme Court Upholds Validity of UP Madrasa Act
DNA Video
DNA: US Presidential Elections and its Global Implications
DNA Video
DNA: Yogi Adityanath’s Winning Formula for Upcoming Elections!
DNA Video
DNA Exclusive: Khalistani Attack on Hindu Temple in Canada Exposed
DNA Video
DNA: Ban on Muslims in Tirupati Temple?
DNA Video
DNA: Violence 2.0 in Bangladesh!
DNA Video
DNA: Ruckus over Lord Ram in JNU!
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK